Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...

10. Q. My tirzepatide is labeled “for research use only.” I should be in the clear, right? A. No. For more insight on “research use only” GLP-1s, please see my prior article here.

The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...

Tirzepatide, the active ingredient in Eli Lilly's diabetes drug Mounjaro, may be an effective alternative to painful daily treatment for a rare disorder, according to research published Jan. 29 in ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.

"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking on its effects on cardiovascular outcomes," said Packer. "This is the ...

This review, coupled with the latest research in the field ... Wegovy and Rybelsus, while tirzepatide is the active ingredient in Mounjaro and Zepbound. Nearly 2% of the U.S. population received ...

"We were struck by the high rate of discontinuation," said Tricia Rodriguez, a Truveta research scientist and ... semaglutide, or tirzepatide between January 2018 and December 2023.

New study shows tirzepatide reduces LV mass and heart fat in obesity-related HFpEF, potentially improving heart failure outcomes.

This study adds to a growing body of research documenting vision problems ... were prescribed semaglutide or tirzepatide due to diabetes or obesity, along with other cardiovascular conditions ...

Recent research suggests these drugs could help ... and Mounjaro or Zepbound (tirzepatide). There were other barriers to access: The brand-name versions of the drugs are expensive, in most cases ...